
Over 32,000 medical cannabis studies in 10 years
A bibliometric review of 32,000 publications on medical cannabis from 2013-2023 (NORML). Methodological quality, geography, safety, and the Polish perspective.

A bibliometric review of 32,000 publications on medical cannabis from 2013-2023 (NORML). Methodological quality, geography, safety, and the Polish perspective.

Adaptogens reduce stress by modulating the HPA axis and Hsp72 proteins. Ashwagandha lowers cortisol by 27.9%, rhodiola reduces burnout by 42%. Learn about dosing and interactions.

CBD for social phobia - studies, dosing, safety. Bergamaschi 2011: 600 mg of CBD reduced anxiety before public speaking in 80% of participants.

CBD oils 2026 - extraction, spectrum, dosing, interactions. Sublingual bioavailability 13-19% (PMC, 2020). A complete guide for beginners.

How to take CBD? Comparison of 4 methods: sublingually (13-19%), orally (6-15%), inhalation (30-35%), topically. Duration of action and dosing (PMC, 2020).

CBD - properties, effects, legality in Poland 2026. Formula C21H30O2, ECS mechanism, oils and dry matter. WHO recognized CBD as safe at doses up to 1500 mg (WHO, 2018).

How does CBD work? The endocannabinoid system, CB1/CB2 receptors, 5-HT1A, TRPV1, PPARγ. Bioavailability 13-19% sublingually (Frontiers in Pharmacology, 2020).

CBD and ADHD - research analysis 2026. Neurobiology, interactions with methylphenidate, dosing. Cooper 2017: 30% reduction in impulsivity in the Sativex group (PMC).

CBD for allergies - what do studies say about mast cells and Th2 cytokines. Allergies affect 30-40% of the population in Europe (EAACI, 2023). Interactions with cetirizine and steroids.

CBD for chronic pain: TRPV1/5-HT1A mechanisms, Boehnke 2022 studies (44% reduction in opioids), dosing 30-300 mg/day, fibromyalgia, neuropathy, osteoarthritis.

CBD for endometriosis - mechanisms, dosing, studies. Endometriosis affects 190 million women (WHO, 2023). Read about the ECS, pelvic pain, and scientific evidence.

What is CBC? Cannabichromene - the third most important cannabinoid of cannabis. It acts on TRPA1/TRPV, supports neurogenesis and skin health. The CBC market is growing at 27% per year.




Are you over 18 years old?
Book with you